The University of Tennessee Health Science Center

Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes. (2024) Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, et al. Journal article Proposal for standardized ultrasound analysis of the salivary glands: Part 1 submandibular gland (2024) Hoffman HT, Koch M, Witt RL, Ryan WR, Zenk J, Katz P, Rahmati R, et al. Journal article, Original article Role of Surgical Pathologist for the Detection of Immuno-oncologic Predictive Factors in Non-small Cell Lung Cancers (2023) Mohanty SK, Mishra SK, Amin MB, Agaimy A, Fuchs F Journal article, Review article Guiding Individualized Patient' Care: Emerging Roles of Pathology in the Era of Immune-oncological Therapy (2023) Agaimy A, Amin MB Journal article Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy (2023) Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, Khan A, et al. Journal article Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. (2023) Rubin MA, Amin MB, Compérat E, Gill A, Hartmann A, Menon S, Raspollini M, et al. Journal article Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)]. (2023) Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, et al. Journal article, Erratum Letter regarding “diagnosis and treatment of arterial hypertension 2021” (2022) Ix JH, Tomson CR, Cheung AK, Mann J, Cushman WC, Cheung M, Chang TI Journal article Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification (2022) Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, et al. Journal article WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer (2022) Kench JG, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, et al. Journal article, Review article